Nephros Inc (NEPH)

[seven-up]

Multiple product lines based on proprietary filtration technology
- Ultrafilters for dialysis water and bicarbonate
- Ultrafilters to aid in infection control in hospitals
- Hemodiafiltration systems to provide dialysis for end stage renal patients
• Ultrafilter business unit has $100M+ revenue potential:
- Distributor-based sales model into dialysis clinics and hospitals
- ASHRAE 188-2015, a recently approved industry guideline that is
generating high-levels of focus on waterborne pathogen protection
- Multiple partnering opportunities for ultrafilters as OEM components
• Hemodiafiltration (HDF) System business unit has $100M+ revenue
potential with minimal market penetration
- 4% market share of dialysis patients = $100M in revenue from
disposables from HDF system
• Royalties and profit sharing from license to CamelBak® in Military
Recreation market